http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2572162-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bb2eff32b894adcc76eab8bdc3d8485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52f13745b432b0991ced3fcaf8476343
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-02
filingDate 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1004b3dc71ba583363202764f1bce89c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d38bf0c15b968a925f1fbc9ab5fe209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa9932fe3016e17f48cc6f6b5e79ee18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_172e7b46641b91ad3c2437a5fb81ae6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2231d7b6cee74770255c256995c5270
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b9066f3ed72d72f2a7c9b65238dc59
publicationDate 2015-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2572162-C1
titleOfInvention Method of treatment mastitis in cows
abstract FIELD: veterinary medicine. n SUBSTANCE: saline solution is exposed to electromagnetic radiation of extremely high-frequency band for at least 30 minutes. The distance from the irradiator to the cup (the contents of 45-50 ml) is 14-15 cm, the frequency is 42194±20 MHz. The exposure is carried out once at a wavelength λ equal to 7.1 mm. The irradiated solution is administered daily intracisternally, immediately after milking. The treatment is continued for at least 5 days to complete recovery. n EFFECT: increase in efficiency and reduction in the duration of treatment, prevention of relapse of inflammatory pathological process in the mammary gland and nipples by the administration of environmentally safe solution that causes the activation of non-specific resistance and normalization of the inflammatory process. n 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2704317-C1
priorityDate 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2345796-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445134-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2171309-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25195395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453625657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500734

Total number of triples: 29.